Skip to content
★ Sign in to follow
JK

Jason Kolbert

Lisata Therapeutics, Inc.
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€3,569
▼ Sales (0 ops.)
—

Latest filing published 19 Dec 2011 for LISATA THERAPEUTICS, INC., €1,308.

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Jason Kolbert: trading record in brief

All filings by Jason Kolbert on record concern Lisata Therapeutics, Inc. The record holds 5 filings, for trades running from 9 December 2011 to 15 December 2011.

The open-market record is one-sided, with 5 purchases worth €3,569 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

A typical purchase (the median) is worth €494.

On 19 December 2011 came the latest disclosure, an open-market purchase for €1,308 in Lisata Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jason Kolbert

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    See RemarksExecutivesLisata Therapeutics, Inc.
    1,699 USD0SEC
    2,900 shares@ US$0.586Common Stock, $0.001 par valueSEC:0001144204-11-070481:0
    Canonical exit: 14 Mar 2012 (T+90)
  • ▲
    See RemarksExecutivesLisata Therapeutics, Inc.
    58 USD0SEC
    100 shares@ US$0.5848Common Stock, $0.001 par valueSEC:0001144204-11-070481:1
    Canonical exit: 14 Mar 2012 (T+90)
  • ▲
    See RemarksExecutivesLisata Therapeutics, Inc.
    557 USD0SEC
    1,000 shares@ US$0.5568Common Stock, $0.001 par valueSEC:0001144204-11-069631:0
    Canonical exit: 8 Mar 2012 (T+90)
  • ▲
    See RemarksExecutivesLisata Therapeutics, Inc.
    651 USD0SEC
    1,100 shares@ US$0.5915Common Stock, $0.001 par valueSEC:0001144204-11-069631:1
    Canonical exit: 12 Mar 2012 (T+90)
  • ▲
    See RemarksExecutivesLisata Therapeutics, Inc.
    1,718 USD0SEC
    2,900 shares@ US$0.5925Common Stock, $0.001 par valueSEC:0001144204-11-069631:2
    Canonical exit: 12 Mar 2012 (T+90)

5 of 5 declarations